# The Effect of Metamin 3D on the Lipid and Glucose in Subjects With Metabolic Syndrome

> **NCT01120873** · PHASE3 · COMPLETED · sponsor: **Taichung Veterans General Hospital** · enrollment: 110 (actual)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **DRUG:** Metamin 3D

## Key facts

- **NCT ID:** NCT01120873
- **Lead sponsor:** Taichung Veterans General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2010-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01120873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01120873, "The Effect of Metamin 3D on the Lipid and Glucose in Subjects With Metabolic Syndrome". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT01120873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*